Home › Heart Diseases › NCT07351656
A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound
Recruiting
Screening for Heart Disease Using AI-Enabled Electrocardiography and Focused Cardiac Ultrasound: the AI CVD Screen Study.
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Adolescents and young adults: Inclusion Criteria: * Enrollment in a high-school, college or a resident in MN during the study period * Age 18-29 years * Informed consent (and assent for minors) Exclusion Criteria: * Presence of a pacemaker or defibrillator * Inability to obtain a quality ECG tracing Community dwelling adults: Inclusion Criteria: • Adult patients (\>30 years of age, with pre-specified subgroups 30-64 and 65+)) Exclusion Criteria: • Inability to provide informed consent to participate in the study Pregnant women: Inclusion Criteria: * Adult female aged 18 to 49 years * Pregnant at the time of enrollment * Receiving obstetric care at identified study site(s) * Willing and able to provide informed consent Exclusion Criteria: • Inability to provide consent
About the study
A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
What is being tested
- Focused Cardiac Ultrasound (diagnostic test)
- 6-Lead AI-ECG (diagnostic test)
- 12-Lead AI-ECG (diagnostic test)
Sponsor: Mayo Clinic · Participants: 19,300 · Started: Mar 9, 2026
Contact the study team
- Amanda Priebe · Phone: 507-422-6932
Official record on ClinicalTrials.gov — NCT07351656
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.